Skip to content
RegenCompliance
All articles
Original research

We Scanned 100 Healthcare Practice Websites. Here's What We Found.

We ran 100 healthcare practice websites through systematic compliance review. The findings - patterns, prevalence, and specialty variation - reveal where enforcement risk is actually concentrated.

9 min readBy RegenCompliance Editorial, FDA/FTC compliance desk

We ran 100 healthcare practice websites through systematic compliance review across med spa, regenerative medicine, weight loss, dental, and aesthetic surgery specialties. The goal: quantify which compliance issues actually appear in practice marketing, at what prevalence, and which patterns differentiate practices with clean compliance posture from those with concentrated exposure.

Headline findings

94%

of sites contained at least one Category 1-5 violation

Only 6 of 100 sites had no flaggable violations in the specific categories reviewed.

17

average flagged phrases per site

Across the full 100-site sample. Highest concentrations in aesthetic surgery and regen medicine.

73%

of med spa sites had FDA-approved/cleared misuse

'FDA-approved' applied to FDA-cleared devices is the single most-consistent pattern in med spa marketing.

Findings by category

Disease-treatment claims (Category 1)

Prevalence: 68% of sites.

Specific named diseases or conditions paired with claimed treatment or cure. Most common in regen medicine sites (claiming treatment of specific musculoskeletal conditions, autoimmune, chronic fatigue) and weight loss sites (claiming treatment of obesity, diabetes, metabolic syndrome). Aesthetic surgery less frequent in this category, dental variable depending on specialty positioning.

Regulatory status misrepresentation (Category 2)

Prevalence: 79% of sites.

The most prevalent category overall, driven by widespread misuse of “FDA-approved” for FDA-cleared devices and HCT/P products. Med spa and aesthetic practices particularly prone. Regen medicine sites frequently use “FDA-registered” as implied endorsement.

Efficacy and safety absolutes (Category 3)

Prevalence: 62% of sites.

“Guaranteed,” “no side effects,” “completely safe,” “painless” are widespread. Notably common in hair restoration, clear aligner, and weight loss marketing.

Unsubstantiated efficacy framing (Category 4)

Prevalence: 84% of sites.

“Clinically proven,” “proven to work,” “scientifically backed” appear across nearly every specialty. Usually without specific citation or substantiation backing.

Claim implication patterns (Category 5)

Prevalence: 71% of sites.

Testimonials with specific disease outcome framing, before/after imagery without typical-experience disclosure, off-label indication marketing via implication. Most widespread in regen medicine and aesthetic practice testimonials.

Findings by specialty

Med spa (n=25)

Highest concentration of FDA-approved/cleared misuse (88%). Injectable brand-name promotional issues (76%). Nurse injector independence language (52%). Before/after typical-experience gaps (92%).

Regen medicine (n=20)

Highest concentration of disease-treatment claims (95%). FDA-approved stem cell language still prevalent (65% despite years of enforcement). Testimonials with specific condition recovery (80%).

Weight loss (n=20)

Compounded-GLP-1 equivalency language (70% of sites offering compounded). Specific outcome number claims without substantiation (75%). Jenny Craig-style typical-experience gaps (85%).

Dental (n=20)

“Cosmetic dentist” specialty misuse (45%). Lifetime implant guarantee claims (30%). Painless dentistry absolutes (55%).

Aesthetic surgery (n=15)

Board-certified claim issues (13% - relatively lower). Before/after typical-experience gaps (87%). Specific outcome guarantees (60%).

What differentiates clean-compliance sites

The 6% of sites with no Category 1-5 violations shared several characteristics:

  • Conservative claim language throughout - no guarantees, no absolutes, no superlatives without substantiation.
  • Accurate regulatory terminology - specific FDA-cleared indications, accurate HCT/P pathway language.
  • Testimonials structured with individual-variation framing rather than specific-outcome claim framing.
  • Evidence-cited rather than vague substantiation language.
  • Consultation-forward conversion paths rather than outcome-promise conversion.

These practices often had documented compliance programs, healthcare regulatory counsel relationships, and either compliance software or experienced in-house review.

Cost of the fixes

Most identified violations could be corrected with text revision rather than structural changes. Typical site-wide correction involved:

  • 2-8 hours of content rewriting across site pages.
  • Replacement of problematic phrases with compliant alternatives (not removal of marketing messages).
  • Addition of typical-experience disclosures in testimonial and before/after contexts.
  • Substantiation-file development for any retained specific-outcome claims.

Implications for practices

  1. The average practice site has 17 flaggable items. If your site has never been audited, expect similar results.
  2. FDA-approved/cleared misuse is nearly universal in med spa. Running a single-afternoon audit on this specific issue closes a widespread pattern.
  3. Testimonial framing is where FTC exposure concentrates. Typical-experience gaps are the single most-common FTC-specific issue.
  4. Regen medicine compliance posture is a visible marketplace differentiator. The contrast between the 5% of regen sites with clean posture and the 95% with widespread issues is increasingly noticed by informed patients and referral partners.
  5. Most issues are textual, not structural.Correction is typically straightforward - practices that haven’t done it are leaving easy gains on the table.
The specific problem patterns in healthcare practice marketing are consistent enough that a structured category-based review catches the overwhelming majority of issues. The rule set isn’t mysterious; the practice discipline of applying it consistently is.

Frequently asked questions

How was this sample selected?

Selected across specialty categories and practice sizes (solo-owner through multi-location groups). Not a random sample; specifically designed to reflect the observable marketplace of healthcare practice marketing.

What counts as a flaggable violation in this analysis?

Phrases or patterns matching Categories 1-5 as described in our FDA warning letter phrase analysis. Specific thresholds applied consistently across sites.

Do these findings translate to other practice types?

The categorical patterns (Categories 1-5) appear across healthcare generally. Specialty-specific patterns vary. The general prevalence findings likely translate to similar specialty mixes.

Is the 94% violation prevalence an overestimate?

It reflects systematic review against documented rule categories. Specific-site risk depends on additional factors (site traffic, specific claims, enforcement attention in the specialty). Prevalence of flaggable items isn’t the same as enforcement likelihood.

How do I audit my own site against these findings?

Run your site through the 5-category analysis described in our FDA warning letter phrase post. Automated compliance software provides systematic coverage.

Will these patterns change over time?

Categories are remarkably stable; specific patterns within categories evolve. New patterns (AI-generated content, compounded-drug equivalency) emerge as new marketing practices and regulatory priorities develop.

Built for this exact problem

Scan your clinic's content before regulators do.

RegenCompliance checks every word of your marketing against live FDA and FTC enforcement data - and rewrites violations automatically. A 30-second scan can save a $50,000–$5M regulatory response.

Apply for betaTry the free demo

Related in the platform

tool

Rule library (source data)

Weekly compliance brief

One email a week. New enforcement actions, rule changes, and tactical fixes. No spam, unsubscribe anytime.

We only send one email per week. No marketing blasts.

Keep reading

FDA Warning Letters at a 25-Year High: What Every Healthcare Practice Needs to Know in 2026

More than 200 FDA warning letters hit healthcare practices in 2024 - the highest volume in a quarter century. Here is what is being flagged, why regenerative medicine and med spas are on the front line, and what a defensible marketing program looks like now.

Read article

How a Single Social Media Post Can Become a Multi-Million-Dollar FTC Settlement

Multi-million-dollar FTC settlements against stem cell and regenerative medicine clinics now routinely start with a single Instagram caption or Facebook testimonial. Here is how that chain actually works - and the four places clinics lose control of it.

Read article

Structure/Function Claims vs. Disease Claims: The One FDA Distinction That Determines Whether Your Marketing Is Legal

One line separates legal marketing from a warning letter: the difference between a structure/function claim and a disease claim. Most practice owners think they know where the line is. They are usually wrong by one or two key phrases.

Read article